Company intelligence / Profile preview

JW Theriac Pharmaceutical

Boston, Massachusetts, United Statesjw-theriac.com ↗
Ownership
Private
Development stage
Other
01

Overview

JW Theriac Pharmaceutical serves as the US-based research subsidiary of South Korea’s JW Pharmaceutical. It focuses on global open innovation and expanding an innovative new drug pipeline by leveraging proprietary platforms such as “JWELRY” and “CLOVER.” The company specializes in oncology, immunology, regenerative medicine, metabolic disease research, and collaborates with target-oriented biotech companies worldwide. Its current programs include small molecule inhibitors targeting key pathways like Wnt/β-catenin and STAT proteins; several candidates are advancing toward first-in-human studies but remain preclinical as of now.[3][4][8]

Therapeutic areas
OncologyMetabolic DisordersImmunologyOther
Modalities
Small molecules[8]Biologics[9]Cell therapies (including immune cell therapies)[6][9]New modalities (unspecified)[9]
Industry
Biotech
02

Drug pipeline

4 assets

WE

Preclinical

3 more assets in the full pipeline.

03

Partnerships

Engaged in global open innovation partnerships including collaborations with ARCH Venture Partners’ ATS program,[9], plus ongoing search for joint research partners among leading biotech companies worldwide.

Beyond the preview

Go deeper on JW Theriac Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JW Theriac Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call